Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
36.24    1.52 (4.38%)
Bid:
36.38
Ask:
36.52
Spread: 0.14 (0.385%)
Market Cap: £579.48m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

Share Buyback Programme

24 Feb 2023 07:00

RNS Number : 8971Q
Hays PLC
24 February 2023
 

 

FOR IMMEDIATE RELEASE

 

24 February 2023

Hays plc

Share Buyback Programme

On 20 June 2022, Hays plc (the "Company") announced that it had entered into a non-discretionary arrangement with Jefferies International Limited ("Jefferies") in relation to the programme to repurchase the Company's ordinary 1 pence shares up to the value of c.£63million.

In the six months ending 31 December 2022, 50.2million shares were purchased and cancelled, at a cost of £57.6million. On 23 February 2023, the Company entered into a further agreement with Jefferies in relation to the purchase by Jefferies of ordinary shares up to the value of £18,200,000. The programme will be executed by Jefferies from the date of this announcement and will end no later than 30 June 2023.

As announced on 28 April 2022, the purpose of the programme is to reduce the total issued share capital of the Company. Jefferies will purchase the Company's ordinary shares as principal and sell them on to the Company in accordance with the terms of their engagement. The Company intends to cancel the shares it purchases through the programme.

Any share purchases will be made in accordance with certain pre-set parameters set out in the terms of Jefferies engagement, the general authority of the Company to repurchase shares granted by shareholders at the Company's annual general meeting held on 9 November 2022 (which permits the Company to purchase no more than 162,523,118 of the Company's ordinary shares, taking into account the amount of shares already repurchased using this authority under the buyback programmes announced on 23 September 2020, 29 November 2021 and 28 April 2022), the EU Market Abuse Regulation (596/2014) as it applies in the UK, the Commission Delegated Regulation (2016/1052) as it applies in the UK and Chapter 12 of the Financial Conduct Authority's Listing Rules.

 

For further information please contact:

David Phillips, Head of Investor Relations and ESG on +44 (0) 333 010 7122, or ir@hays.com

LEI code: 213800QC8AWD4BO8TH08

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSNKNBBPBKDKBB
Date   Source Headline
9th Dec 20242:37 pmRNSDB pension scheme de-risked with full buy-in
2nd Dec 202411:55 amRNSTotal Voting Rights
28th Nov 202412:14 pmRNSDirector/PDMR Shareholding
26th Nov 202411:02 amRNSHolding(s) in Company
20th Nov 20242:27 pmRNSBoard Committee Changes
20th Nov 20242:07 pmRNSResult of AGM
1st Nov 202410:00 amRNSTotal Voting Rights
25th Oct 20242:10 pmRNSDirector/PDMR Shareholding
23rd Oct 20241:49 pmRNSHolding(s) in Company
16th Oct 20242:01 pmRNSHolding(s) in Company
11th Oct 20247:00 amRNSFirst Quarter Trading Statement
10th Oct 20244:44 pmRNSDirector/PDMR Shareholding - Amendment
10th Oct 202412:45 pmRNSDirector/PDMR Shareholding
7th Oct 20243:14 pmRNSDirector/PDMR Shareholding
7th Oct 202412:43 pmRNSAnnual Financial Report
1st Oct 202410:00 amRNSTotal Voting Rights
27th Sep 20242:39 pmRNSDirector/PDMR Shareholding
12th Sep 20243:52 pmRNSDirector/PDMR Shareholding
9th Sep 20242:45 pmRNSDirector/PDMR Shareholding
6th Sep 20242:16 pmRNSDirector/PDMR Shareholding
4th Sep 20244:30 pmRNSDirector/PDMR Shareholding
2nd Sep 202410:27 amRNSTotal Voting Rights
22nd Aug 20247:00 amRNSFinal Results
20th Aug 20245:00 pmRNSCompany Secretary Change
20th Aug 20244:02 pmRNSHolding(s) in Company
1st Aug 202410:15 amRNSBlock listing Interim Review
1st Aug 202410:00 amRNSTotal Voting Rights
11th Jul 20247:00 amRNSFourth Quarter Trading Statement
1st Jul 202410:00 amRNSTotal Voting Rights
6th Jun 20243:43 pmRNSDirector/PDMR Shareholding
3rd Jun 202410:00 amRNSTotal Voting Rights
3rd May 20242:07 pmRNSResponse to Voting Results
1st May 202410:00 amRNSTotal Voting Rights
16th Apr 20247:00 amRNSThird Quarter Trading Statement
12th Apr 202410:06 amRNSDirector/PDMR Shareholding
9th Apr 202410:22 amRNSHolding(s) in Company
8th Apr 20244:00 pmRNSDirector/PDMR Shareholding
2nd Apr 202410:03 amRNSTotal Voting Rights
28th Mar 202412:20 pmRNSDirector/PDMR Shareholding
20th Mar 20242:40 pmRNSDirector/PDMR Shareholding
1st Mar 202410:00 amRNSTotal Voting Rights
22nd Feb 20247:00 amRNSHalf-year Report
20th Feb 20243:15 pmRNSAppointment of Non-Executive Directors
20th Feb 20243:10 pmRNSBoard and Committee Changes
1st Feb 202411:00 amRNSBlock listing Interim Review
1st Feb 202410:00 amRNSTotal Voting Rights
9th Jan 20247:00 amRNSSecond Quarter Trading Statement
2nd Jan 202410:00 amRNSTotal Voting Rights
13th Dec 20237:00 amRNSDirector/PDMR Shareholding
7th Dec 202311:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.